Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450

X Ding, DC Spink, JK Bhama, JJ Sheng, AD Vaz and MJ Coon

Division of Environmental Disease Prevention, New York State Department of Health, Albany, 12201-0509, USA., dingx@wadsworth.org

The herbicide 2,6-dichlorobenzonitrile (DCBN) is known to cause tissue- specific toxicity at very low doses in the olfactory mucosa of rodents. The toxicity of DCBN is reportedly cytochrome P450 (P450) dependent, but the isoforms involved have not been identified, and the effects of this agent on humans are not known. In the present study, DCBN metabolism was examined with microsomes and with purified P450s in a reconstituted system. Rat and rabbit olfactory microsomes act on DCBN to form DCBN-protein adducts as well as two metabolite peaks, designated M1 and M2, identified through high performance liquid chromatography with radiometric detection. The activity of rat olfactory microsomes in DCBN metabolism is much higher than that of liver or lung microsomes. Of seven purified rabbit P450s known to be expressed in the olfactory mucosa, including 1A2, 2A10/11, 2B4, 2E1, 2G1, and 3A6, the 2A10/11 preparation is the most active, producing M2 as well as DCBN-protein adducts; P450 2E1 is the only other active isoform. The addition of purified epoxide hydrolase (EC 4.2.1.63) to the reconstituted enzyme system leads to the formation of M1 and decreased formation of M2. It seems that M1 and M2 are derived from an epoxide intermediate that also forms covalent protein adducts. Gas chromatography- and liquid chromatography-mass spectrometry analyses of nasal microsomal DCBN metabolites and DCBN-glutathione conjugates indicated that the major reactive intermediate may be 2,3-oxo-DCBN and that M1 may be 2,3-dihydroxy-6-chlorobenzonitrile, whereas M2 may correspond to a monohydroxy-DCBN. Interestingly, heterologously expressed human P450s 2A6 and 2E1, but not 1A2, are active in the metabolism of DCBN, forming protein adducts as well as M2. Thus, the preferential expression of P450s of the 2A subfamily in olfactory tissue suggests a molecular basis for the tissue-specific toxicity of the herbicide and may have important implications for risk assessment in humans.

Volume 49, Issue 6, pp. 1113-1121, 06/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. M. Jeffrey, M. J. Iatropoulos, and G. M. Williams Nasal Cytotoxic and Carcinogenic Activities of Systemically Distributed Organic Chemicals Toxicol Pathol, December 1, 2006; 34(7): 827 - 852. [Abstract] [Full Text] [PDF]

				M. B. Genter Molecular Biology of the Nasal Airways: How Do We Assess Cellular and Molecular Responses in the Nose? Toxicol Pathol, April 1, 2006; 34(3): 274 - 280. [Abstract] [Full Text] [PDF]

				A.-L. Minn, H. Pelczar, C. Denizot, M. Martinet, J.-M. Heydel, B. Walther, A. Minn, H. Goudonnet, and Y. Artur CHARACTERIZATION OF MICROSOMAL CYTOCHROME P450-DEPENDENT MONOOXYGENASES IN THE RAT OLFACTORY MUCOSA Drug Metab. Dispos., August 1, 2005; 33(8): 1229 - 1237. [Abstract] [Full Text] [PDF]

				E. Tyden, H. Tjalve, and P. Larsson Metabolic Activation of 2,6-Xylidine in the Nasal Olfactory Mucosa and the Mucosa of the Upper Alimentary and Respiratory Tracts in Rats Toxicol. Sci., October 1, 2004; 81(2): 263 - 272. [Abstract] [Full Text] [PDF]

				X. Zhuo, J. Gu, M. J. Behr, P. J. Swiatek, H. Cui, Q.-Y. Zhang, Y. Xie, D. N. Collins, and X. Ding Targeted Disruption of the Olfactory Mucosa-Specific Cyp2g1 Gene: Impact on Acetaminophen Toxicity in the Lateral Nasal Gland, and Tissue-Selective Effects on Cyp2a5 Expression J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 719 - 728. [Abstract] [Full Text] [PDF]

				E. Piras, A. Franzen, E. L. Fernandez, U. Bergstrom, F. Raffalli-Mathieu, M. Lang, and E. B. Brittebo Cell-specific Expression of CYP2A5 in the Mouse Respiratory Tract: Effects of Olfactory Toxicants J. Histochem. Cytochem., November 1, 2003; 51(11): 1545 - 1555. [Abstract] [Full Text] [PDF]

				A. Franzen, C. Carlsson, I. Brandt, and E. B. Brittebo Isomer-Specific Bioactivation and Toxicity of Dichlorophenyl Methylsulphone in Rat Olfactory Mucosa Toxicol Pathol, June 1, 2003; 31(4): 364 - 372. [Abstract] [PDF]

				J. Sheng, Z. Hua, J. Guo, M. Caggana, and X. Ding Identification of a New Human CYP2A Gene Fragment with Close Linkage to CYP2GP1 Drug Metab. Dispos., January 1, 2001; 29(1): 4 - 7. [Abstract] [Full Text]

				T. Su, Z. Bao, Q.-Y. Zhang, T. J. Smith, J.-Y. Hong, and X. Ding Human Cytochrome P450 CYP2A13: Predominant Expression in the Respiratory Tract and Its High Efficiency Metabolic Activation of a Tobacco-specific Carcinogen, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Cancer Res., September 1, 2000; 60(18): 5074 - 5079. [Abstract] [Full Text]

				Q.-Y. Zhang, D. Dunbar, and L. Kaminsky Human Cytochrome P-450 Metabolism of Retinals to Retinoic Acids Drug Metab. Dispos., March 1, 2000; 28(3): 292 - 297. [Abstract] [Full Text] [PDF]

				X. Zhuo, J. Gu, Q.-Y. Zhang, D. C. Spink, L. S. Kaminsky, and X. Ding Biotransformation of Coumarin by Rodent and Human Cytochromes P-450: Metabolic Basis of Tissue-Selective Toxicity in Olfactory Mucosa of Rats and Mice J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 463 - 471. [Abstract] [Full Text]

				J. Gu, Q.-Y. Zhang, M. B. Genter, T. W. Lipinskas, M. Negishi, D. W. Nebert, and X. Ding Purification and Characterization of Heterologously Expressed Mouse CYP2A5 and CYP2G1: Role in Metabolic Activation of Acetaminophen and 2,6-Dichlorobenzonitrile in Mouse Olfactory Mucosal Microsomes J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1287 - 1295. [Abstract] [Full Text]

				L. L. Koenigs, R. M. Peter, S. J. Thompson, A. E. Rettie, and W. F. Trager Mechanism-Based Inactivation of Human Liver Cytochrome P450 2A6 by 8-Methoxypsoralen Drug Metab. Dispos., December 1, 1997; 25(12): 1407 - 1415. [Abstract] [Full Text]